Agodichi U Nwosu, MD | |
909 S Mcpherson Church Rd, Fayetteville, NC 28303-5350 | |
(910) 483-0018 | |
Not Available |
Full Name | Agodichi U Nwosu |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 41 Years |
Location | 909 S Mcpherson Church Rd, Fayetteville, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902942931 | NPI | - | NPPES |
128AA | Other | NC | BCBC-NC INDIV |
89128AA | Medicaid | NC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 200001224 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Cape Fear Valley Medical Center | Fayetteville, NC | Hospital |
Entity Name | Carolina Heart Physicians Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154305704 PECOS PAC ID: 9234198821 Enrollment ID: O20041008000392 |
News Archive
Repligen Corporation announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation to RG2833, a selective histone deacetylase 3 inhibitor for the treatment of Friedreich's ataxia. Orphan drug designation qualifies Repligen to receive seven years of marketing exclusivity in the United States if the company is the first to obtain marketing approval for RG2833 for the treatment of Friedreich's ataxia.
A new study conducted at the Michigan State University, USA found that expressive writing might help a person to perform efficiently in an upcoming stressful task.
Walter J. Lukiw, PhD, Associate Professor of Neuroscience and Ophthalmology at LSU Health Sciences Center New Orleans, is the lead author of a paper identifying, for the first time, a specific function of a fragment of ribonucleic acid (RNA), once thought to be no more than a byproduct, in regulating inflammation and the development of Alzheimer's disease.
Raptor Pharmaceutical Corp.,provides updates on timelines related to its clinical programs including the pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Agodichi U Nwosu, MD 909 S Mcpherson Church Rd, Fayetteville, NC 28303-5350 Ph: (910) 483-0018 | Agodichi U Nwosu, MD 909 S Mcpherson Church Rd, Fayetteville, NC 28303-5350 Ph: (910) 483-0018 |
News Archive
Repligen Corporation announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation to RG2833, a selective histone deacetylase 3 inhibitor for the treatment of Friedreich's ataxia. Orphan drug designation qualifies Repligen to receive seven years of marketing exclusivity in the United States if the company is the first to obtain marketing approval for RG2833 for the treatment of Friedreich's ataxia.
A new study conducted at the Michigan State University, USA found that expressive writing might help a person to perform efficiently in an upcoming stressful task.
Walter J. Lukiw, PhD, Associate Professor of Neuroscience and Ophthalmology at LSU Health Sciences Center New Orleans, is the lead author of a paper identifying, for the first time, a specific function of a fragment of ribonucleic acid (RNA), once thought to be no more than a byproduct, in regulating inflammation and the development of Alzheimer's disease.
Raptor Pharmaceutical Corp.,provides updates on timelines related to its clinical programs including the pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
› Verified 8 days ago
Kenneth Melton, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 557 Sandhurst Dr, Fayetteville, NC 28304 Phone: 910-484-8114 Fax: 910-484-1564 | |
Kenneth Russell Manning, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-609-6910 Fax: 910-609-5219 | |
San San Wai, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2300 Ramsey St, Va Medical Center, Fayetteville, NC 28301 Phone: 910-488-2120 | |
Dr. Sabena Johnson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2300 Ramsey St, Fayetteville, NC 28301 Phone: 910-488-2120 | |
Dr. Stephen S Logue, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1843 Quiet Cv, Fayetteville, NC 28304 Phone: 910-483-8080 Fax: 910-483-3258 | |
David Tat, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1601 Owen Dr, Fayetteville, NC 28304 Phone: 910-678-0100 Fax: 910-678-0110 | |
Dr. Ghanshyam Pradyumna Dwivedi, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1778 Metromedical Dr, Fayetteville, NC 28304 Phone: 910-483-4680 Fax: 910-484-2704 |